For: | Ang C, Doyle E, Branch A. Bisphosphonates as potential adjuvants for patients with cancers of the digestive system. World J Gastroenterol 2016; 22(3): 906-916 [PMID: 26811636 DOI: 10.3748/wjg.v22.i3.906] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i3/906.htm |
Number | Citing Articles |
1 |
Dan-Ting Wen, Zheng Xu, Mei-Ling Xuan, Guo-Rong Liang, Wei-Ling Zheng, Xue-Fang Liang, Jing Xiao, Xiao-Yun Wang. Prognostic Effect of Bisphosphonate Exposure for Patients With Diagnosed Solid Cancer: A Systematic Review With Meta-Analysis of Observational Studies. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00495
|
2 |
Zhiwei Shao, Haoqi Pan, Sheng Tu, Jingying Zhang, Sheng Yan, Anwen Shao. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00801
|
3 |
Nabil A. Alhakamy, Osama A. A. Ahmed, Usama A. Fahmy, Shadab Md. Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer. Pharmaceuticals 2021; 14(8): 729 doi: 10.3390/ph14080729
|
4 |
Zhengchao Zhang, Dong Li, Heng Yun, Jie Tong, Wei Liu, Keqiang Chai, Tongwei Zeng, Zhenghua Gao, Yongqiang Xie. Opportunities and challenges of targeting c-Met in the treatment of digestive tumors. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.923260
|
5 |
Zintle Mbese, Blessing A. Aderibigbe. Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone Cancer. International Journal of Molecular Sciences 2021; 22(13): 6869 doi: 10.3390/ijms22136869
|
6 |
A M Osadchuk, I L Davydkin, T A Gricenko, M A Osadchuk. Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem. Terapevticheskii arkhiv 2019; 91(8): 135 doi: 10.26442/00403660.2019.08.000228
|
7 |
Yini Ma, Xiu Cao, Guojuan Shi , Tianlu Shi. MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target. Current Pharmaceutical Design 2021; 27(19): 2264 doi: 10.2174/1381612826666201029095702
|
8 |
Xian-Bin Cheng, Bo Fu, Xing-Zhao Li, Yang Jiang. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis. Pathology - Research and Practice 2020; 216(6): 152949 doi: 10.1016/j.prp.2020.152949
|
9 |
Dragana Bjelić, Matjaž Finšgar. Bioactive coatings with anti-osteoclast therapeutic agents for bone implants: Enhanced compliance and prolonged implant life. Pharmacological Research 2022; 176: 106060 doi: 10.1016/j.phrs.2022.106060
|
10 |
Lin Chen, Zhicheng Dai, Huangrong Song, Jiafeng Zhang, Tuo Li. Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023). Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1473756
|
11 |
Hongli Zhang, Qingqing Feng, Wei-Dong Chen, Yan-Dong Wang. HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers. International Journal of Molecular Sciences 2018; 19(11): 3295 doi: 10.3390/ijms19113295
|
12 |
Ashraf Bahi el-din Abd, Usama Ahmed Fahmy. Alendronate Sodium Combined Glatiramer Acetate Nanocomplex Suppresses Pancreatic Cancer Cell Growth. International Journal of Pharmacology 2024; 20(7): 1281 doi: 10.3923/ijp.2024.1281.1291
|
13 |
Hai-Jun Wang, Yu Liu, Bao-Jun Zhou, Zhan-Xue Zhang, Ai-Ying Li, Ran An, Bin Yue, Li-Qiao Fan, Yong Li. Inhibitory effects of CP on the growth of human gastric adenocarcinoma BGC-823 tumours in nude mice. Journal of International Medical Research 2018; 46(5): 1756 doi: 10.1177/0300060518761505
|